Our technological platform, our expertise and our data are currently fully mobilized to serve:

  • French and European health authorities on the monitoring of visits to pharmacies and the evolution of drug consumption in the population
  • of the international network GIHSN (Global Influenza Hospital Surveillance Network) - public partnership -private under the aegis of the Foundation for the Epidemiology of Flu, associating resources from the US and Chinese CDCs and mobilizing around 100 hospitals in 23 countries - which generates epidemiological and virological data on hospitalized patients for acute respiratory disease
  • from our European partners in Germany, Italy, Spain, Portugal, Belgium, Poland, with whom we are working to set up in the very short term, as part of a European call, a sentinel observatory for the monitoring of the spread of non-severe cases of Covid-19 , key in monitoring the crisis

Study objectives

This study, carried out over the period S8 and S12 2020 for the EPI-PHARE group of ANSM , mobilizes the data of a large pharmacy panel (nearly 11,000 pharmacies, ie more than one in 2 French pharmacy) collected and processed daily in a fully industrialized and auditable manner.

The main objective of the study is to highlight the resilience of the network, its capacity of the pharmacy network to absorb suddenly and suddenly - an increase in visits to pharmacy pharmacies in the context of the containment measures that came into force at 12 noon on 03/17/2020.

Discussion: through this study, OpenHealth wishes to recall the French specificity of its pharmacy network which must be considered as a regulatory lever in the measures of the coming days to prevent any saturation of our care system .

Summary of results and discussion

very significant increases from W8 to W12 2020 compared to last year, mainly driven by non-prescription

less marked developments in the West , much more significant in the East and especially in Ile-de -France

constantly increasing evolutions over the weeks

• A S12 2020 week marked by a very strong increase in passages, concentrated on Monday 16 and Tuesday 17, particularly on non-prescription .

Discussion

• These elements demonstrate the capacity for mobilization of the pharmacy network in the short term and brutally well as its resilience in the current context .

• This network - in daily contact with the entire population - is a key lever for efficiency in health crisis management . Concretely, community pharmacists could be mobilized in the short term to carry out a massive campaign of tests and / or be the platform for the dissemination of health products within the local territory.

Since S8 2020, the total number of additional visits to pharmacies is constantly increasing

Source: OpenHealth extrapolated panel; data updated at 03/22/2020 at 07:50

In total, over the past 5 weeks, while 13.5 million additional passages in pharmacies have been observed, the network is not saturated

Comparison of cumulative of weeks S8 2020 (starting on Monday 17/02/2020) up to S12 2020 (stopped on Friday 03/20/2020)

Source: OpenHealth extrapolated panel; data updated at 03/22/2020 at 07:50

https://www.insee.fr/fr/statistiques/3676599?sommaire = 3696937

This last week, the number of visits has doubled on the single day of Monday March 16 before suddenly retracting Friday March 20

Source: OpenHealth extrapolated panel; data updated at 03/22/2020 at 07:50

This excess of passages in pharmacies is observed throughout the national territory and is particularly marked in IDF and Grand-Est

Comparison of cumulative of weeks S8 2020 (starting on Monday 17/02/2020) up to S12 2020 (stopped on Friday 03/20/2020)

Source: OpenHealth extrapolated panel; data updated at 03/22/2020 at 07:50

The passages in non-prescription pharmacies mainly explain this evolution

Comparison of cumulative of weeks S8 2020 (starting on Monday 17/02/2020) up to S12 2020 (stopped on Friday 03/20/2020)

Source: OpenHealth extrapolated panel; data updated at 03/22/2020 at 07:50

Literacy

1 - The data source: Panel extrapolated OHC

• OHC (OpenHealth Company) daily collects and processes 100% of sales tickets from 10,966 pharmacies (Selfcare, dermocosmetics, prescription, veterinarian, etc.)

• The OHC panel is representative of the national universe in terms of overall turnover, location, VAT structure

• OHC sell-out data (national and territorial) are based on a single panel

• A panel which is particularly representative of the large Selfcare pharmacies:

> Taking into account several criteria including overall sales, geographic area, location

> The multi-layered model is a multi-dimensional model of the universe of pharmacy. There are as many aspects of dimensions as there are stratification criteria

> The panel was reinforced on pharmacies of over € 5M. (68% panellist coverage on this pharmacy group)

2 - Definition of study indicators

Number of dispensations: http: / /success.openhealth.fr/fr/articles/3194348-nombre-de-dispensations

Average volume per dispensation: http://success.openhealth.fr/fr/articles/3396196-volume-moyen-par-dispensation

Pharmacy Monitoring Analysis: http: / /success.openhealth.fr/fr/articles/3839223-pharmacy-monitoring-analysis

Pharmacy Monitoring Evolution: http: / /success.openhealth.fr/fr/articles/3827973-pharmacy-monitoring-evolution

Relevant dispensation: http: //success.openhealth.fr/fr/articles/3804193-suivi-de-dispensations-pertinentes

3 - Study methodology

Product scope : All products dispensed in town pharmacies

Geographical scope : Metropolitan France excluding Corsica
Geographical granularity : Administrative regions and Total

Temporal perimeter: weeks S5 to W12 2019 and 2020
Time granularity : weekly
Definitions of a week : from Monday at 00:00 until Sunday at 23:59
Definition of a weekly comparison : change between a week in the year 2020 with the same week number of the year 2019
Study start date : S8 2020, starting Monday 02/17/2020
Sales for weeks S11 and S12 2020 are estimates, and in fact are not yet fixed

Indicators:
- Number of dispensations in total, out and on prescription
- Sales volumes in consumer units (boxes) in total, excluding and on prescription
Additional: difference for each of these 2 indicators, over a given period, between the value observed with the value observed over the same period in year N-1


Did this answer your question?